Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

Elevated serum lactate dehydrogenase (sLDH) is associated with poor clinical outcomes in patients with stage IV metastatic melanoma (MM). It is currently unknown if sLDH elevation correlates with distinct molecular, metabolic, or immune features of melanoma metastases. The identification of such fea...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Grant M., Carapeto, Fernando C. L., Joon, Aron Y., Haydu, Lauren E., Chen, Huiqin, Wang, Fuchenchu, Van Arnam, John S., McQuade, Jennifer L., Wani, Khalida, Kirkwood, John M., Thompson, John F., Tetzlaff, Michael T., Lazar, Alexander J., Tawbi, Hussein A., Gershenwald, Jeffrey E., Scolyer, Richard A., Long, Georgina V., Davies, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666738/
https://www.ncbi.nlm.nih.gov/pubmed/33016647
http://dx.doi.org/10.1002/cam4.3474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666738/
https://www.ncbi.nlm.nih.gov/pubmed/33016647
http://dx.doi.org/10.1002/cam4.3474

Ejemplares similares